These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22567777)

  • 1. What is the current FDA-approved therapy to treat pancreatic insufficiency for children with cystic fibrosis?
    Mennitt D
    NASN Sch Nurse; 2012 Mar; 27(2):67-8. PubMed ID: 22567777
    [No Abstract]   [Full Text] [Related]  

  • 2. High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better".
    Lebenthal E
    J Pediatr Gastroenterol Nutr; 1994 May; 18(4):423-5. PubMed ID: 8071775
    [No Abstract]   [Full Text] [Related]  

  • 3. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Konstan MW; Stern RC; Trout JR; Sherman JM; Eigen H; Wagener JS; Duggan C; Wohl ME; Colin P
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1365-71. PubMed ID: 15606399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency.
    Taylor JR; Gardner TB; Waljee AK; Dimagno MJ; Schoenfeld PS
    Aliment Pharmacol Ther; 2010 Jan; 31(1):57-72. PubMed ID: 19804466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations.
    Kraisinger M; Hochhaus G; Stecenko A; Bowser E; Hendeles L
    J Clin Pharmacol; 1994 Feb; 34(2):158-66. PubMed ID: 8163716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nutrition and substitution therapy in mucoviscidosis].
    Henker J
    Z Arztl Fortbild (Jena); 1982 Mar; 76(6):250-2. PubMed ID: 7113270
    [No Abstract]   [Full Text] [Related]  

  • 7. Pancreatic enzyme replacement therapy for enterally fed patients with cystic fibrosis.
    Nicolo M; Stratton KW; Rooney W; Boullata J
    Nutr Clin Pract; 2013 Aug; 28(4):485-9. PubMed ID: 23753650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth of human milk-fed and formula-fed infants with cystic fibrosis.
    Holliday KE; Allen JR; Waters DL; Gruca MA; Thompson SM; Gaskin KJ
    J Pediatr; 1991 Jan; 118(1):77-9. PubMed ID: 1986104
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of exocrine pancreatic insufficiency: what gastroprotection do pancreatic enzymes provide?].
    Zylberberg P; Delchier JC
    Gastroenterol Clin Biol; 1993; 17(11):816-22. PubMed ID: 8143947
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
    Duhamel JF; Vidailhet M; Le Luyer B; Douchain F; Jehanne M; Clavel R; Guillot M
    Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee.
    Borowitz DS; Grand RJ; Durie PR
    J Pediatr; 1995 Nov; 127(5):681-4. PubMed ID: 7472816
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin E status in children with cystic fibrosis and pancreatic insufficiency.
    Huang SH; Schall JI; Zemel BS; Stallings VA
    J Pediatr; 2006 Apr; 148(4):556-559. PubMed ID: 16647424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Creon 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis.
    Trapnell BC; Maguiness K; Graff GR; Boyd D; Beckmann K; Caras S
    J Cyst Fibros; 2009 Dec; 8(6):370-7. PubMed ID: 19815466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
    Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term experience with ZENPEP in infants with exocrine pancreatic insufficiency associated with cystic fibrosis.
    Wooldridge JL; Schaeffer D; Jacobs D; Thieroff-Ekerdt R
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):612-5. PubMed ID: 25050848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.
    Freswick PN; Reid EK; Mascarenhas MR
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic enzyme supplementation.
    Wier HA; Kuhn RJ
    Curr Opin Pediatr; 2011 Oct; 23(5):541-4. PubMed ID: 21799412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis.
    Haupt ME; Kwasny MJ; Schechter MS; McColley SA
    J Pediatr; 2014 May; 164(5):1110-1115.e1. PubMed ID: 24560182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of cimetidine as an adjunct to supplemental pancreatic enzymes in patients with cystic fibrosis.
    Hubbard VS; Dunn GD; Lester LA
    Am J Clin Nutr; 1980 Nov; 33(11):2281-6. PubMed ID: 7435406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.